Masterproeven

905 masterproeven gevonden

Targeted long read sequencing to identify missing genetic variation

De Viaene Wannes, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Kim De Leeneer
Layman summary with societal impact The revised criteria for diagnosing patients with NF1 emphasize the importance of genetic variant detection. This research focuses on optimizing current techniques to efficiently and precisely identify variants in potential NF1 patients, which could be a very helpful tool in diagnosis. The ability to detect …
NF1 genetics Short read sequencing gDNA cDNA

Mass Spectrometry Data Cleaning for Improved Identification of Post-Translational Modifications

Marckx Nathan, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Lennart Martens
With this research, the fields of proteomics and bioinformatics could be significantly advanced through improved data pre-processing, leading to enhanced LC-MS data quality. By effectively calibrating proteomics data, this study enables more accurate peptide and protein identification, as well as improved post-translational modification (PTM) analysis. Enhanced PTM identification rates could …

Assessing database construction and reduction methods in metaproteomics

Cattrijsse Wout, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Lennart Martens
This study focuses on rather fundamental research concepts and is therefore further removed from a direct societal impact than translational research. However, this study aims to provide insights into how we can analyse metaproteomic samples with more certainty and accuracy. This is vital if we want to gather truthful and …
Metaproteomics Mass spectrometry-based proteomics False discovery rate (FDR) Target-decoy approach (TDA) Database construction Database reduction

Investigating the effects of deubiquitinase-inhibition in hepatocellular carcinoma cell lines

D'Hoore Kathelijne, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Marleen Van Troys
Advanced hepatocellular carcinoma (HCC) remains one of the main causes of cancer death worldwide and was reported by the Surveillance Epidemiology End Results (SEER) as the ‘fastest increasing cause of cancer-related death’. In Belgium, the number of new diagnoses increased from 277 in 2004 to 761 in 2021 (Belgian Cancer …

Investigating the effects of deubiquitinase-inhibition in hepatocellular carcinoma cell lines

lema davina, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Marleen Van Troys
Advanced hepatocellular carcinoma (HCC) remains one of the main causes of cancer death worldwide and was reported by the Surveillance Epidemiology End Results (SEER) as the ‘fastest increasing cause of cancer-related death’. In Belgium, the number of new diagnoses increased from 277 in 2004 to 761 in 2021 (Belgian Cancer …

Non-invasive prenatal screening for the presymptomatic detection of pregnancy complications

Nuwel Caitlin, Master of science in de Biomedische Wetenschappen, 2024
Promotor: Bjorn Menten
Pregnancy complications continue to be a huge burden on prenatal healthcare systems and pregnant women and their fetuses. Today, there is still a lack of accurate screening methods to predict pregnancy complications, such as preeclampsia, early on in pregnancy. Advancements in prenatal screening methods can provide significant benefits to pregnant …
Preeclampsia, cfDNA, DNA methylation analysis, early prediction

Hartvariabiliteit als prognostische waarde van een goed herstel na een acuut myocardinfarct

Diependael Helena, Master of science in de Geneeskunde, 2024
Promotor: Said Hachimi-Idrissi
Via deze masterproef wordt de prognostische waarde van hartritmevariabiliteit (HRV) onderzocht bij mensen die een AMI doorgemaakt hebben. Kan de HRV, berekend op basis van een ECG-ritmestrook van 10 seconden, gebruikt worden om de mortaliteit of morbiditeit na STEMI of NSTEMI te voorspellen? De HRV wordt berekend aan de hand …
mortaliteit hartritmevariabiliteit acuut myocardinfarct STEMI NSTEMI complicaties prognose

DE IMPACT VAN WIJZIGINGEN IN GINA-RICHTLIJNEN OP ASTMA-MANAGEMENT BIJ VOLWASSEN MET MILD TOT MATIG ASTMA GEBASEERD OP REAL LIFE TRIALS

Barbry Giel, Master of science in de Geneeskunde, 2024
Promotor: Guy Brusselle
Beschrijving van de data achter de de wijzigingen in GINA richtlijnen doorheen de jaren voor de behandeling van mild en matig astma.
Mild/matig astma volgens GINA richtlijnen

Conflict or integration of palliative care in phase one trials of patients with cancer. A qualitative study.

De Roeck Roselynn, Master of science in de Geneeskunde, 2024
Promotor: Kim Beernaert
Deze thesis vormt de basis ter uitwerking van een standaardintegratie van palliatieve zorgen tijdens fase I klinisch onderzoek voor patiënten met kanker. Het betreft kwalitatief onderzoek uitgevoerd via semigestructureerd interviews met onderzoekers, oncologen, medewerkers van de dienst palliatieve zorg en patiënten met kanker in fase I studies. Het onderzoek gaat …
palliatieve zorg fase I klinisch onderzoek

Autologous hematopoietic stem cell transplantation in children with brain tumors: an analysis of the event-free survival and quality of life in long-term survivors.

Speybroeck Céline, Master of science in de Geneeskunde, 2024
Promotor: M. Victoria Bordon Cueto de Braem
Deze retrospectieve studie onderzoekt de effectiviteit en veiligheid van autologe stamceltransplantatie in de behandeling van pediatrische hersentumoren. Dit gebeurt via analyse van de overall survival, event free survival en de kwaliteit van leven in lange termijn overlevers.
Stem cell transplantation Brain tumors Long-term consequences pediatric

« Previous | Next »